FDA Inspection 1214839 — Sojitz Corporation of America

Sojitz Corporation of America — FEI 2432520

The FDA completed an inspection of Sojitz Corporation of America on August 11, 2023 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 11, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
New York, NY (United States)

Additional Details

FSVP

Citations

IDCFRDescription
1825421 CFR 1.502(a)Develop FSVP
1833421 CFR 1.510(b)(1)Record - translate to English